Gov. Markell and Delaware Bio Honors AstraZeneca for 10 Years in State

Award recipients recognized for Innovation, Service, and Excellence in Government

Members of Delaware’s bioscience community honored three industry leaders at the Delaware Bio Annual Awards Gala on Wednesday, April 29. We also celebrated the ten-year anniversary of AstraZeneca’s decision to locate its U.S. headquarters in Wilmington, Delaware.

 Recipients of the 2009 Delaware Bio awards, which go to individuals who have made outstanding contributions to the biosciences in Delaware are:

• Innovation: Dr. Barry Marrs, Chief Scientific Officer of Athena Biotechnologies,
• Service: Dr. David Weir, Director of the Office of Economic Innovation and Partnerships (OEIP) at the University of Delaware,
• Government Official: Senator Thomas R. Carper, United States Senate.

The keynote speaker for the evening was Delaware Governor Jack Markell and many in the room had stories to share about AstraZeneca’s decision to locate their U.S. headquarters in Delaware.